Literature DB >> 21431511

The isolation and culture of human cord blood-derived mesenchymal stem cells under low oxygen conditions.

Anita Laitinen1, Johanna Nystedt, Saara Laitinen.   

Abstract

There is growing evidence that low oxygen conditions are beneficial for in vitro stem cell culturing. Mimicking the physiological oxygen tension of the placental stem cell niche in cell expansion can -ultimately result in more robust cell expansion. Growing evidence also suggests that hypoxic preconditioning of cells may improve therapeutic outcomes. Here we describe a scalable method that enables mesenchymal stromal cell expansion from virtually every cord blood unit, including those that would normally be disqualified from banking. In addition, the cells obtained by the described method fulfill exclusively the mesenchymal stromal cell characteristics defined by the International Society for Cellular Therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431511     DOI: 10.1007/978-1-60761-999-4_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue.

Authors:  Erja Kerkelä; Tanja Hakkarainen; Tuomas Mäkelä; Mari Raki; Oleg Kambur; Lotta Kilpinen; Janne Nikkilä; Siri Lehtonen; Ilja Ritamo; Roni Pernu; Mika Pietilä; Reijo Takalo; Tatu Juvonen; Kim Bergström; Eija Kalso; Leena Valmu; Saara Laitinen; Petri Lehenkari; Johanna Nystedt
Journal:  Stem Cells Transl Med       Date:  2013-06-03       Impact factor: 6.940

2.  Dissection of the cord blood stromal component reveals predictive parameters for culture outcome.

Authors:  Mario Barilani; Cristiana Lavazza; Mariele Viganò; Tiziana Montemurro; Valentina Boldrin; Valentina Parazzi; Elisa Montelatici; Mariacristina Crosti; Monica Moro; Rosaria Giordano; Lorenza Lazzari
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

3.  Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells.

Authors:  Mika Pietilä; Sami Palomäki; Siri Lehtonen; Ilja Ritamo; Leena Valmu; Johanna Nystedt; Saara Laitinen; Hannnu-Ville Leskelä; Raija Sormunen; Juha Pesälä; Katrina Nordström; Ari Vepsäläinen; Petri Lehenkari
Journal:  Stem Cells Dev       Date:  2011-07-20       Impact factor: 3.272

4.  Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro.

Authors:  Erica B Peters; Betty Liu; Nicolas Christoforou; Jennifer L West; George A Truskey
Journal:  Ann Biomed Eng       Date:  2015-03-17       Impact factor: 3.934

5.  Metabolic glycoengineering of mesenchymal stromal cells with N-propanoylmannosamine.

Authors:  Suvi Natunen; Milla Lampinen; Heli Suila; Ilja Ritamo; Virve Pitkänen; Alison V Nairn; Jarkko Räbinä; Saara Laitinen; Kelley W Moremen; Werner Reutter; Leena Valmu
Journal:  Glycobiology       Date:  2013-05-25       Impact factor: 4.313

6.  Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.

Authors:  Hye Jin Jin; Yun Kyung Bae; Miyeon Kim; Soon-Jae Kwon; Hong Bae Jeon; Soo Jin Choi; Seong Who Kim; Yoon Sun Yang; Wonil Oh; Jong Wook Chang
Journal:  Int J Mol Sci       Date:  2013-09-03       Impact factor: 5.923

7.  CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells.

Authors:  Mika Pietilä; Siri Lehtonen; Elina Tuovinen; Kaarina Lähteenmäki; Saara Laitinen; Hannu-Ville Leskelä; Antti Nätynki; Juha Pesälä; Katrina Nordström; Petri Lehenkari
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Flavin mononucleotide-based fluorescent proteins function in mammalian cells without oxygen requirement.

Authors:  Janine Walter; Sascha Hausmann; Thomas Drepper; Michael Puls; Thorsten Eggert; Marcel Dihné
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

9.  Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell marker.

Authors:  Tia Hirvonen; Heli Suila; Sari Tiitinen; Suvi Natunen; Marja-Leena Laukkanen; Annika Kotovuori; Mirka Reinman; Tero Satomaa; Kaija Alfthan; Saara Laitinen; Kristiina Takkinen; Jarkko Räbinä; Leena Valmu
Journal:  Biores Open Access       Date:  2013-10

10.  Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning.

Authors:  Lotta Kilpinen; Ulla Impola; Lotta Sankkila; Ilja Ritamo; Maria Aatonen; Sami Kilpinen; Jarno Tuimala; Leena Valmu; Jouko Levijoki; Piet Finckenberg; Pia Siljander; Esko Kankuri; Eero Mervaala; Saara Laitinen
Journal:  J Extracell Vesicles       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.